Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
早些時候宣佈，Aligos Therapeutics已獲得一份價值130萬美元的美國國立衛生研究院合同，用於對治療Covid-19的化合物進行臨床開發
Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
早些時候宣佈，Aligos Therapeutics已獲得一份價值130萬美元的美國國立衛生研究院合同，用於對治療Covid-19的化合物進行臨床開發
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。